Jennifer Davis

Jennifer Davis

Auto-generated profile, based on publicly available information

Jennifer Davis

University of Washington

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Developmental Cell
Verified
Journal Article
Closed access
JDJennifer Davis
Jennifer Davis
ABAdam R. Burr
Adam R. Burr
GDGregory F. Davis
Gregory F. Davis
LBLutz Birnbaumer
Lutz Birnbaumer
JMJeffery D Molkentin
Jeffery D Molkentin

15 February 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SCShanshan Cai
Shanshan Cai
MZMingyue Zhao
Mingyue Zhao
BZBo Zhou
Bo Zhou
AYAkira Yoshii
Akira Yoshii
DBDarrian Bugg
Darrian Bugg
RTRong Tian
Rong Tian
Innate immune cells play important roles in tissue injury and repair following acute myocardial infarction (MI). Although reprogramming of macrophage metabolism has been observed during inflammation and resolution phases, the mechanistic link to macrophage phenotype is not fully understood. In this study, we found that myeloid-specific deletion (mKO) of mitochondrial complex I protein, encoded by Ndufs4, reproduced the proinflammatory metabolic profile in macrophages and exaggerated the response to LPS. Moreover, mKO mice showed increased mortality, poor scar formation, and worsened cardiac function 30 days after MI. We observed a greater inflammatory response in mKO mice on day 1 followed by increased cell death of infiltrating macrophages and blunted transition to the reparative phase during post-MI days 3–7. Efferocytosis was impaired in mKO macrophages, leading to lower expression of antiinflammatory cytokines and tissue repair factors, which suppressed the proliferation and activation of myofibroblasts in the infarcted area. Mitochondria-targeted ROS scavenging rescued these impairments, improved myofibroblast function in vivo, and reduced post-MI mortality in mKO mice. Together these results reveal a critical role of mitochondria in inflammation resolution and tissue repair via modulation of efferocytosis and crosstalk with fibroblasts. These findings have potential significance for post-MI recovery as well as for other inflammatory conditions.

1 May 2014 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
JDJennifer Davis
Jennifer Davis
JMJeffery D Molkentin
Jeffery D Molkentin

8 August 2017 in Circulation
Verified
Journal Article
Closed access
PDF file
JMJeffery D Molkentin
Jeffery D Molkentin
DBDarrian Bugg
Darrian Bugg
NGNatasha Ghearing
Natasha Ghearing
LDLisa E. Dorn
Lisa E. Dorn
PKPeter Kim
Peter Kim
JDJennifer Davis
Jennifer Davis
Background: In the heart, acute injury induces a fibrotic healing response that generates collagen-rich scarring that is at first protective but if inappropriately sustained can worsen heart disease. The fibrotic process is initiated by cytokines, neuroendocrine effectors, and mechanical strain that promote resident fibroblast differentiation into contractile and extracellular matrix–producing myofibroblasts. The mitogen-activated protein kinase p38α ( Mapk14 gene) is known to influence the cardiac injury response, but its direct role in orchestrating programmed fibroblast differentiation and fibrosis in vivo is unknown. Methods: A conditional Mapk14 allele was used to delete the p38α encoding gene specifically in cardiac fibroblasts or myofibroblasts with 2 different tamoxifen-inducible Cre recombinase–expressing gene–targeted mouse lines. Mice were subjected to ischemic injury or chronic neurohumoral stimulation and monitored for survival, cardiac function, and fibrotic remodeling. Antithetically, mice with fibroblast-specific transgenic overexpression of activated mitogen-activated protein kinase kinase 6, a direct inducer of p38, were generated to investigate whether this pathway can directly drive myofibroblast formation and the cardiac fibrotic response. Results: In mice, loss of Mapk14 blocked cardiac fibroblast differentiation into myofibroblasts and ensuing fibrosis in response to ischemic injury or chronic neurohumoral stimulation. A similar inhibition of myofibroblast formation and healing was also observed in a dermal wounding model with deletion of Mapk14 . Transgenic mice with fibroblast-specific activation of mitogen-activated protein kinase kinase 6–p38 developed interstitial and perivascular fibrosis in the heart, lung, and kidney as a result of enhanced myofibroblast numbers. Mechanistic experiments show that p38 transduces cytokine and mechanical signals into myofibroblast differentiation through the transcription factor serum response factor and the signaling effector calcineurin. Conclusions: These findings suggest that signals from diverse modes of injury converge on p38α mitogen-activated protein kinase within the fibroblast to program the fibrotic response and myofibroblast formation in vivo, suggesting a novel therapeutic approach with p38 inhibitors for future clinical application.

1 May 2016 in Cell
Verified
Journal Article
Closed access
JDJennifer Davis
Jennifer Davis
LDL. Craig Davis
L. Craig Davis
RCRobert N. Correll
Robert N. Correll
CMCatherine A. Makarewich
Catherine A. Makarewich
JSJennifer A. Schwanekamp
Jennifer A. Schwanekamp
JMJeffery D Molkentin
Jeffery D Molkentin

21 January 2011 in Circulation Research
Verified
Journal Article
Closed access
PDF file
IKIzhak Kehat
Izhak Kehat
JDJennifer Davis
Jennifer Davis
MTMalte Tiburcy
Malte Tiburcy
FAFederica Accornero
Federica Accornero
MSMarc K. Saba-El-Leil
Marc K. Saba-El-Leil
JMJeffery D Molkentin
Jeffery D Molkentin
Rationale:: An increase in cardiac afterload typically produces concentric hypertrophy characterized by an increase in cardiomyocyte width, whereas volume overload or exercise results in eccentric growth characterized by cellular elongation and addition of sarcomeres in series. The signaling pathways that control eccentric versus concentric heart growth are not well understood. Objective:: To determine the role of extracellular signal-regulated kinase 1 and 2 (ERK1/2) in regulating the cardiac hypertrophic response. Methods and Results:: Here, we used mice lacking all ERK1/2 protein in the heart (Erk1 −/− Erk2 fl/fl-Cre ) and mice expressing activated mitogen-activated protein kinase kinase (Mek)1 in the heart to induce ERK1/2 signaling, as well as mechanistic experiments in cultured myocytes to assess cellular growth characteristics associated with this signaling pathway. Although genetic deletion of all ERK1/2 from the mouse heart did not block the cardiac hypertrophic response per se, meaning that the heart still increased in weight with both aging and pathological stress stimulation, it did dramatically alter how the heart grew. For example, adult myocytes from hearts of Erk1 −/− Erk2 fl/fl-Cre mice showed preferential eccentric growth (lengthening), whereas myocytes from Mek1 transgenic hearts showed concentric growth (width increase). Isolated adult myocytes acutely inhibited for ERK1/2 signaling by adenoviral gene transfer showed spontaneous lengthening, whereas infection with an activated Mek1 adenovirus promoted constitutive ERK1/2 signaling and increased myocyte thickness. A similar effect was observed in engineered heart tissue under cyclic stretching, where ERK1/2 inhibition led to preferential lengthening. Conclusions:: Taken together, these data demonstrate that the ERK1/2 signaling pathway uniquely regulates the balance between eccentric and concentric growth of the heart.